RECK and familial pancreatic carcinoma: Moreover, TGF-β1 treatment of Panc-1 cells, a pancreatic cancer cell line, led to a twofold increase in RECK protein levels without any effect on RECK mRNA levels, which was dependent on the activation of the Smad dependent pathway [44].